Clinically Significant Bacteremia
2
0
0
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Related Conditions
Often studied with 8 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 2 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (2)
Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study.
Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to Extended-spectrum Beta-lactamase (ESBL) or Carbapenemase-producing Enterobacteriaceae: an Observational Multinational Study
Research Network
Active Sponsors
- Spanish Network for Research in Infectious Diseases1
- European Society of Clinical Microbiology and Infectious Diseases1
- JESUS RODRIGUEZ BAÑO1
Top Investigators
Hospital Universitario Virgen Macarena, IBIS, Seville, Spain.
Hospital Universitario Reina Sofía/IMIBIC/UCO, Córdoba, Spain.
Spanish Network for Research in Infectious Diseases
Hospital Universitario Virgen Macarena, IBIS, Seville, Spain.
IMIBIC/HURS/UCO, Córdoba, Spain
Related Conditions
- Bacteremia1
- Organ Transplantation1
- Inflammation1
- Bacterial Infections1
- Pathologic Processes1